Mg2+-driven triple nucleic acid cascades amplify Ru-encoded bimetallic MOF sign PFOA monitoring
Analytica Chimica Acta · 2026-06 · 1402 · 345377
DOI: 10.1016/j.aca.2026.345377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-06. Verfasst von Lin-Yi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optic-electric Chemo/Biosensing and Molecular Recognition(Guangxi Minzu University), Education Department of Guangxi Zhuang Autonom…. Hauptthemen laut MEDLINE: Fluorocarbons, Metal-Organic Frameworks, Caprylates, Magnesium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Guangxi Innovation-Driven Development Project, Guangxi Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Perfluoroalkyl substances (PFAS) represent significant environmental hazards due to their exceptional persistence and propensity for bioaccumulation. However, current detection methodologies lack the ultra-trace sensitivity necessary to meet regulatory standards. In this study, we present an innovative electrochemiluminescence (ECL) aptasensor specifically designed for the detection of perfluorooctanoic acid (PFOA), which integrates three advanced strategies. First, a NiRu bimetallic metal-organic framework (MOF) luminophore was synthesized through hydrothermal encapsulation of Ru(bpy)32+, resulting in a 3.8-fold enhancement in ECL intensity compared to the monometallic Ni-MOF. Second, an enzyme-free triple nucleic acid amplification cascade, catalyzed by Mg2+ ions, was developed by combining catalytic hairpin assembly with T-shaped DNAzyme circuits, achieving a 105-fold signal amplification. Third, a ferrocene-mediated "on-off-on" quenching-recovery mechanism was employed to suppress background signals effectively. This integrated sensing platform attained an unprecedented detection limit of 23.7 fM (0.0098 ng/L), exceeding the U.S. Environmental Protection Agency's drinking water standard by a factor of 400, while demonstrating recovery rates between 95.1% and 97.7% in authentic water samples. This work represents the first MOF-based ECL approach that synergistically combines dual-metal enhancement with metal-ion-catalyzed nucleic acid amplification, offering a versatile framework for the sensitive monitoring of trace environmental contaminants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optic-electric Chemo/Biosensing and Molecular Recognition(Guangxi Minzu University), Education Department of Guangxi Zhuang Autonomous Region, Guangxi Key Laboratory of Chemistry and Engineering of For…
- Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, China.
Förderung
- Guangxi Innovation-Driven Development Project
- Guangxi Key Research and Development Program
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards Research
Zitieren
APA
Liu, L. Y., Xie, Y. Q., Peng, Y., Ren, S. Y., Lai, K. D., Tan, X. C., Huang, K. J., & Feng, D. F. (2026). Mg2+-driven triple nucleic acid cascades amplify Ru-encoded bimetallic MOF sign PFOA monitoring. Analytica Chimica Acta, 1402, 345377. https://doi.org/10.1016/j.aca.2026.345377
Vancouver
Liu LY, Xie YQ, Peng Y, Ren SY, Lai KD, Tan XC, et al. Mg2+-driven triple nucleic acid cascades amplify Ru-encoded bimetallic MOF sign PFOA monitoring. Analytica Chimica Acta. 2026;1402:345377. doi:10.1016/j.aca.2026.345377
BibTeX
@article{Liu2026,
author = {Liu, Lin-Yi and Xie, Ya-Qian and Peng, Yue and Ren, Si-Yi and Lai, Ke-Dao and Tan, Xue-Cai and Huang, Ke-Jing and Feng, De-Fen},
title = {Mg2+-driven triple nucleic acid cascades amplify Ru-encoded bimetallic MOF sign PFOA monitoring},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1402},
pages = {345377},
doi = {10.1016/j.aca.2026.345377}
}
EUVIMED